KRAS and non-small cell lung carcinoma: All six SMARCA4-mutant SCLC-Y lines also harboured TP53 mutations, but other genomic alterations previously observed to co-occur with SMARCA4-mutant NSCLC, such as STK11, KEAP1, and KRAS, were not identified (Supplementary Table S8).